ZUSDURI J Code: J9282

Drug & Product Overview

HCPCS Descriptor Mitomycin, intravesical instillation, 1 mg

HCPCS Added Date January 1, 2026

Manufacturer UroGen Pharma

Route of Administration Intravesical Instillation

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Kit

About ZUSDURI

Zusduri is a medication aligned to the HCPCS J Code: J9282 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravesical instillation route and manufactured by UroGen Pharma.

According to CMS Drug Use Information: This medication is used to treat a certain type of cancer (bladder cancer). It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
72493-0106-03	Zusduri	UroGen Pharma, Inc	80	Kit

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

ZUSDURI Pricing & Reimbursement

J9282 Private Payer Reimbursement

$277.27 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Mitomycin 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9281	UroGen Pharma	Mitomycin	Mitomycin pyelocalyceal instillation, 1 mg
J9282	UroGen Pharma	Mitomycin	Mitomycin, intravesical instillation, 1 mg

ZUSDURI CPT Administration Codes

CPT Code	Description
51720	Bladder instillation of anticarcinogenic agent, including retention time

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

ZUSDURI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC)

Frequently Asked Questions

Is there a manufacturer-published ZUSDURI billing and coding guide?

Billing and coding information for ZUSDURI can be found through UroGen Pharma. Visit Here →

Is there an available ZUSDURI patient assistance program?

ZUSDURI patient assistance information can be found through UroGen Pharma. Visit Here →

Where can I find ZUSDURI prescribing information?

ZUSDURI prescribing information can be found at the link below. Visit Here →

Where can I find ZUSDURI side effect information?

ZUSDURI side effect information can be found through MedlinePlus. Visit Here →

Does billing ZUSDURI require JZ/JW wastage modifiers?

CMS does not include ZUSDURI (J9282) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9282. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.